According to Harvard Bioscience's latest financial reports the company's current earnings are โน91.39 Million. In 2024 the company made an earning of -โน1.02 Billion a decrease over its 2023 earnings that were of -โน0.23 Billion. The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2025 (TTM) | -โน4.95 Billion | 388.8% |
2024 | -โน1.02 Billion | 356.38% |
2023 | -โน0.23 Billion | -72.15% |
2022 | -โน0.8 Billion | 6456.43% |
2021 | -โน12.14 Million | -98.08% |
2020 | -โน0.64 Billion | 32.53% |
2019 | -โน0.48 Billion | -31.01% |
2018 | -โน0.7 Billion | 243.9% |
2017 | -โน0.21 Billion | -24.66% |
2016 | -โน0.27 Billion | -14.69% |
2015 | -โน0.32 Billion | -181.68% |
2014 | โน0.38 B | -9.97% |
2013 | โน0.42 B | 120% |
2012 | โน0.19 B | -50.9% |
2011 | โน0.39 B | -52.51% |
2010 | โน0.82 B | -2.53% |
2009 | โน0.85 B | 28.26% |
2008 | โน0.66 B | -20.05% |
2007 | โน0.82 B | 13.96% |
2006 | โน0.72 B | 17.59% |
2005 | โน0.61 B | 57.37% |
2004 | โน0.39 B | -37.31% |
2003 | โน0.62 B | 208.03% |
2002 | โน0.20 B | -168.71% |
2001 | -โน0.3 Billion | -66.89% |
2000 | -โน0.9 Billion |